Cerebral venous thrombosis in Latin America: A critical review of risk factors, clinical and radiological characteristics

BackgroundCerebral venous thrombosis (CVT) is a rare disease that frequently occurs in young women of childbearing age, with variable clinical presentation in regions with limited access to diagnostic imaging or specialized neurological care. In the last decade, there has been an increase in the number of studies on CVT in Latin America, which may contribute to a better epidemiological description of the disease in this region and, consequently, its early diagnosis. ObjectivesOur study aims to review the risk factors, clinical and radiological characteristics of CVT in Latin America, being critically compared with data from world literature. MethodsPubMed, ScienceDirect, BVS, and Scopus were searched to identify studies reporting CVT in Latin American countries published up to July 2022. We excluded case reports and case series reporting ResultsWe identified a total of 3714 studies and 26 qualified for the quantitative analysis, which described 1486 cases of CVT. Headache was the most frequent symptom (82.1%) and the use of oral contraceptives in women was the main risk factor (46.7%). The transverse sinus was the most frequent location of the thrombus (52%). The treatment used most in the acute phase was heparin (88.5%) and oral anticoagulation was widely used at hospital discharge (67.8%). The mortality was low (6.5%), and most patients achieved complete recovery (75.3%). ConclusionDespite considerable dissimilarities in studies between countries, particularities were identified in the risk factors of CVT in Latin America compared to other regions of the world.

Automated summary

This study reviewed the risk factors, clinical and radiological characteristics of cerebral venous thrombosis (CVT) in Latin America and compared the findings with data from worldwide literature. The results showed that headache was the most common symptom, oral contraceptives were the main risk factor, heparin was commonly used in the acute phase, and oral anticoagulation was widely used at hospital discharge. The mortality rate was low, and most patients achieved complete recovery in Latin America.